BSX vs STT · P/E 20, rev $10.65B vs P/E 17, rev $7.84B
Boston Scientific Corp (BSX) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
State Street Corp (STT) is a asset management company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the BSX and STT stock pages for the full models.
Not investment advice.